基于视频的远程医疗访问与心力衰竭患者的药物坚持之间的关联:回顾性跨部分研究
Yaguang Zheng1, Samrachana Adhikari2, Xiyue Li2
1New York University Rory Meyers College of Nursing, 433 1st Avenue, New York, NY, 10010, United States, 1 212-998-5170.
JMIR cardio
|December 5, 2024
概括
对于心力衰竭患者的远程医疗访问显示了与面对面访问相比,类似的药物坚持率. 这表明远程医疗是一种可行的选择,可以保持坚持,提供方便并克服运输障碍.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
- 数字健康数字健康
背景情况:
- 在临床实践中,COVID-19大流行加速了远程医疗的采用.
- 通过远程医疗治疗治疗心力衰竭患者的药物坚持仍未得到充分研究.
- 了解远程医疗对坚持治疗的影响对于心力衰竭管理至关重要.
研究的目的:
- 为了比较心力衰竭患者的远程医疗和面对面访问之间的药物坚持.
- 评估访问类型和药物坚持率之间的关联.
主要方法:
- 对9521名成人心力衰竭患者进行了回顾性横截面研究 (2020年4月1日至10月1日).
- 药物坚持度以180天内被覆盖日数比例 (PDC) 衡量 (如果PDC≥0.8则坚持).
- 患者分为单独远程医疗或单独面对面的组;使用Poisson和后勤回归.
主要成果:
- 远程医疗 (0.794) 和面对面 (0.812) 组之间的PDC平均值没有显著差异 (比率比率0.99,P=.09).
- 类似的遵守率:69%的远程医疗与71.6%的面对面访问 (几率比率0.94,P=.12).
- 经过对年龄,性别,种族和保险等共变量进行调整后,结果一致.
结论:
- 远程医疗访问与心力衰竭患者的面对面访问相比,与药物坚持率相比较.
- 提供现实世界的证据支持远程医疗作为心力衰竭的有效门诊护理方法.
- 远程医疗提供了一种方便的替代方案来维持药物坚持,解决潜在的运输挑战.
相关概念视频
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
01:26Heart Failure Drugs: Inotropic Agents
517
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
517
01:28Mitral Regurgitation IV: Nursing Management
2
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
2
01:20Rheumatic Heart Disease IV: Nursing Management
3
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
3